Hyponatremia in cirrhosis and end-stage liver disease: Treatment with the vasopressin v2-receptor antagonist tolvaptan

Paul Gaglio, Kwaku Marfo, Chiodo Joseph Chiodo

Research output: Contribution to journal › Review article › peer-review

36 Scopus citations

Fingerprint

Dive into the research topics of 'Hyponatremia in cirrhosis and end-stage liver disease: Treatment with the vasopressin v2-receptor antagonist tolvaptan'. Together they form a unique fingerprint.

Medicine & Life Sciences